268 related articles for article (PubMed ID: 25894862)
1. The basic helix-loop-helix transcription factor E47 reprograms human pancreatic cancer cells to a quiescent acinar state with reduced tumorigenic potential.
Kim S; Lahmy R; Riha C; Yang C; Jakubison BL; van Niekerk J; Staub C; Wu Y; Gates K; Dong DS; Konieczny SF; Itkin-Ansari P
Pancreas; 2015 Jul; 44(5):718-27. PubMed ID: 25894862
[TBL] [Abstract][Full Text] [Related]
2. Nicotine promotes initiation and progression of KRAS-induced pancreatic cancer via Gata6-dependent dedifferentiation of acinar cells in mice.
Hermann PC; Sancho P; Cañamero M; Martinelli P; Madriles F; Michl P; Gress T; de Pascual R; Gandia L; Guerra C; Barbacid M; Wagner M; Vieira CR; Aicher A; Real FX; Sainz B; Heeschen C
Gastroenterology; 2014 Nov; 147(5):1119-33.e4. PubMed ID: 25127677
[TBL] [Abstract][Full Text] [Related]
3. New insights into plasticity of pancreatic cancer: cancer to acinar cell reprogramming by the basic helix-loop-helix transcription factor E47.
Bailey JM; Hendley AM; Maitra A
Pancreas; 2015 Jul; 44(5):683-5. PubMed ID: 26061556
[No Abstract] [Full Text] [Related]
4. NFATc1 Links EGFR Signaling to Induction of Sox9 Transcription and Acinar-Ductal Transdifferentiation in the Pancreas.
Chen NM; Singh G; Koenig A; Liou GY; Storz P; Zhang JS; Regul L; Nagarajan S; Kühnemuth B; Johnsen SA; Hebrok M; Siveke J; Billadeau DD; Ellenrieder V; Hessmann E
Gastroenterology; 2015 May; 148(5):1024-1034.e9. PubMed ID: 25623042
[TBL] [Abstract][Full Text] [Related]
5. Induced PTF1a expression in pancreatic ductal adenocarcinoma cells activates acinar gene networks, reduces tumorigenic properties, and sensitizes cells to gemcitabine treatment.
Jakubison BL; Schweickert PG; Moser SE; Yang Y; Gao H; Scully K; Itkin-Ansari P; Liu Y; Konieczny SF
Mol Oncol; 2018 Jun; 12(7):1104-1124. PubMed ID: 29719936
[TBL] [Abstract][Full Text] [Related]
6. The Id3/E47 axis mediates cell-cycle control in human pancreatic ducts and adenocarcinoma.
Lee SH; Hao E; Kiselyuk A; Shapiro J; Shields DJ; Lowy A; Levine F; Itkin-Ansari P
Mol Cancer Res; 2011 Jun; 9(6):782-90. PubMed ID: 21498546
[TBL] [Abstract][Full Text] [Related]
7. E47 Governs the MYC-CDKN1B/p27
Scully KM; Lahmy R; Signaevskaia L; Sasik R; Medal R; Kim H; French R; James B; Wu Y; Lowy AM; Itkin-Ansari P
Cell Mol Gastroenterol Hepatol; 2018; 6(2):181-198. PubMed ID: 30003124
[TBL] [Abstract][Full Text] [Related]
8. Mist1 regulates pancreatic acinar cell proliferation through p21 CIP1/WAF1.
Jia D; Sun Y; Konieczny SF
Gastroenterology; 2008 Nov; 135(5):1687-97. PubMed ID: 18762186
[TBL] [Abstract][Full Text] [Related]
9. Mist1-KrasG12D knock-in mice develop mixed differentiation metastatic exocrine pancreatic carcinoma and hepatocellular carcinoma.
Tuveson DA; Zhu L; Gopinathan A; Willis NA; Kachatrian L; Grochow R; Pin CL; Mitin NY; Taparowsky EJ; Gimotty PA; Hruban RH; Jacks T; Konieczny SF
Cancer Res; 2006 Jan; 66(1):242-7. PubMed ID: 16397237
[TBL] [Abstract][Full Text] [Related]
10. The acinar regulator Gata6 suppresses KrasG12V-driven pancreatic tumorigenesis in mice.
Martinelli P; Madriles F; Cañamero M; Pau EC; Pozo ND; Guerra C; Real FX
Gut; 2016 Mar; 65(3):476-86. PubMed ID: 25596178
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic effects of an anti-Myc drug on mouse pancreatic cancer.
Stellas D; Szabolcs M; Koul S; Li Z; Polyzos A; Anagnostopoulos C; Cournia Z; Tamvakopoulos C; Klinakis A; Efstratiadis A
J Natl Cancer Inst; 2014 Dec; 106(12):. PubMed ID: 25306215
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional control of autophagy-lysosome function drives pancreatic cancer metabolism.
Perera RM; Stoykova S; Nicolay BN; Ross KN; Fitamant J; Boukhali M; Lengrand J; Deshpande V; Selig MK; Ferrone CR; Settleman J; Stephanopoulos G; Dyson NJ; Zoncu R; Ramaswamy S; Haas W; Bardeesy N
Nature; 2015 Aug; 524(7565):361-5. PubMed ID: 26168401
[TBL] [Abstract][Full Text] [Related]
13. Acinar-to-ductal metaplasia accompanies c-myc-induced exocrine pancreatic cancer progression in transgenic rodents.
Grippo PJ; Sandgren EP
Int J Cancer; 2012 Sep; 131(5):1243-8. PubMed ID: 22024988
[TBL] [Abstract][Full Text] [Related]
14. MiR-143 Targeting TAK1 Attenuates Pancreatic Ductal Adenocarcinoma Progression via MAPK and NF-κB Pathway In Vitro.
Huang FT; Peng JF; Cheng WJ; Zhuang YY; Wang LY; Li CQ; Tang J; Chen WY; Li YH; Zhang SN
Dig Dis Sci; 2017 Apr; 62(4):944-957. PubMed ID: 28194669
[TBL] [Abstract][Full Text] [Related]
15. Context-Dependent Epigenetic Regulation of Nuclear Factor of Activated T Cells 1 in Pancreatic Plasticity.
Chen NM; Neesse A; Dyck ML; Steuber B; Koenig AO; Lubeseder-Martellato C; Winter T; Forster T; Bohnenberger H; Kitz J; Reuter-Jessen K; Griesmann H; Gaedcke J; Grade M; Zhang JS; Tsai WC; Siveke J; Schildhaus HU; Ströbel P; Johnsen SA; Ellenrieder V; Hessmann E
Gastroenterology; 2017 May; 152(6):1507-1520.e15. PubMed ID: 28188746
[TBL] [Abstract][Full Text] [Related]
16. Identification of Sox9-dependent acinar-to-ductal reprogramming as the principal mechanism for initiation of pancreatic ductal adenocarcinoma.
Kopp JL; von Figura G; Mayes E; Liu FF; Dubois CL; Morris JP; Pan FC; Akiyama H; Wright CV; Jensen K; Hebrok M; Sander M
Cancer Cell; 2012 Dec; 22(6):737-50. PubMed ID: 23201164
[TBL] [Abstract][Full Text] [Related]
17. Polycomb repressor complex 1 promotes gene silencing through H2AK119 mono-ubiquitination in acinar-to-ductal metaplasia and pancreatic cancer cells.
Benitz S; Regel I; Reinhard T; Popp A; Schäffer I; Raulefs S; Kong B; Esposito I; Michalski CW; Kleeff J
Oncotarget; 2016 Mar; 7(10):11424-33. PubMed ID: 26716510
[TBL] [Abstract][Full Text] [Related]
18. Origin of pancreatic ductal adenocarcinoma from atypical flat lesions: a comparative study in transgenic mice and human tissues.
Aichler M; Seiler C; Tost M; Siveke J; Mazur PK; Da Silva-Buttkus P; Bartsch DK; Langer P; Chiblak S; Dürr A; Höfler H; Klöppel G; Müller-Decker K; Brielmeier M; Esposito I
J Pathol; 2012 Apr; 226(5):723-34. PubMed ID: 21984419
[TBL] [Abstract][Full Text] [Related]
19. Activation of protein kinase Cδ leads to increased pancreatic acinar cell dedifferentiation in the absence of MIST1.
Johnson CL; Peat JM; Volante SN; Wang R; McLean CA; Pin CL
J Pathol; 2012 Nov; 228(3):351-65. PubMed ID: 22374815
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic reprogramming in Mist1(-/-) mice predicts the molecular response to cerulein-induced pancreatitis.
Mehmood R; Varga G; Mohanty SQ; Laing SW; Lu Y; Johnson CL; Kharitonenkov A; Pin CL
PLoS One; 2014; 9(1):e84182. PubMed ID: 24465395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
